This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slipped 4.71% to $16.78 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.00% to 11,014.89 and Dow Jones Industrial Average falling 1.03% to 33,596.34. Novavax Inc. closed $219.72 short of its 52-week high ($236.50), which the company reached on December 20th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 1.50% to $176.10, Pfizer Inc. (PFE) fell 2.01% to $49.71, and Merck & Co. Inc. (MRK) fell 0.98% to $108.93. Trading volume (4.6 M) remained 666,246 below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 6, 2022.
(END) Dow Jones Newswires
December 06, 2022 17:24 ET (22:24 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.